Cytek Biosciences, Inc.
CTKB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$5,478 | -$5,583 | -$11,402 | $9,643 |
| Dep. & Amort. | $3,060 | $2,988 | $2,884 | $2,741 |
| Deferred Tax | -$2,627 | -$2,056 | -$336 | $0 |
| Stock-Based Comp. | $5,638 | $6,790 | $6,630 | $7,003 |
| Change in WC | -$3,563 | -$785 | $3,029 | -$5,500 |
| Other Non-Cash | -$928 | -$1,246 | -$930 | -$11,890 |
| Operating Cash Flow | -$3,898 | $108 | -$125 | $1,997 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$657 | -$1,577 | -$849 | -$894 |
| Net Acquisitions | $0 | $0 | $0 | -$471 |
| Inv. Purchases | -$59,624 | -$81,262 | -$60,161 | -$107,250 |
| Inv. Sales/Matur. | $79,200 | $66,475 | $70,431 | $45,000 |
| Other Inv. Act. | $1 | -$49 | $31 | $182 |
| Investing Cash Flow | $18,920 | -$16,413 | $9,452 | -$63,433 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $1,946 | $1,243 | -$828 | $2,646 |
| Stock Issued | $0 | $767 | $0 | $0 |
| Stock Repurch. | $29 | -$4,510 | -$10,627 | -$6,991 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$34 | -$102 | -$90 | $705 |
| Financing Cash Flow | $1,941 | -$2,602 | -$11,545 | -$3,640 |
| Forex Effect | $846 | -$921 | -$1,228 | $1,518 |
| Net Chg. in Cash | $17,811 | -$19,829 | -$3,446 | -$63,558 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $75,470 | $95,299 | $98,745 | $162,303 |
| End Cash | $93,281 | $75,470 | $95,299 | $98,745 |
| Free Cash Flow | -$4,553 | -$1,469 | -$976 | $1,094 |